Mobile

Multicenter, open-label, randomized, uncontrolled study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestoden...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-001198-13

Multicenter, open-label, randomized, uncontrolled study to evaluate inhibition of ovulation of two transdermal patch formulations containing 0.55 mg ethinylestradiol and either 1.05 or 2.1 mg gestodene in healthy young female volunteers over a period of 3 treatment cycles

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the study is to evaluate the inhibition of ovulation in treatment cycles 2 and 3 after administration of two different patches containing EE and GSD for 3 treatment cycles.

Critère d'inclusion

  • The trial will be performed in healthy female volunteers. The indended indication is female contraception

Liens